Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)

ClinicalTrials.gov ID: NCT00399919

Public ClinicalTrials.gov record NCT00399919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy pf Propionyl-L-Carnitine in Combination With Monitored Exercise Training in Peripheral Arterial Disease (Intermittent Claudication).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients with peripheral artery disease have decreased blood flow to exercising muscle causing pain. This decreased blood flow to the muscle affects the level of acylcarnitines which in turn decreases the level of carnitine. Carnitine allows muscles to function properly. This study will test the safety and efficacy of Propionyl-L-Carnitine taken in combination with a monitored exercise training program.

Study identification

NCT ID
NCT00399919
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sigma-Tau Research, Inc.
Industry
Enrollment
69 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2006 (Type not available)
Primary completion
Mar 2008 (Actual)
Completion
Mar 2008 (Actual)
Last update posted
Aug 25, 2011

2006 – 2008

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Baptist Clinical Research Pensacola Florida 32501 —
Western Suburban Cardiologists, Ltd. LaGrange Illinois 60525 —
SIU School of Medicine Springfield Illinois 62702 —
University of Massachusetts Medical Center Worchester Massachusetts 01655 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
University of Rochester Medical Center Rochester New York 14618 —
Asheville Cardiology Associates Asheville North Carolina 28803 —
Durham VA Medical Center Durham North Carolina 27705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00399919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2011 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00399919 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →